Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
AustriaStudy on Methotrexate and Adalimumab for Non-Infectious Uveitis in Patients: Evaluating Effectiveness and Safety
SpainStudy on Povetacicept for Patients with Autoimmune Cytopenias (wAIHA, CAD, ITP)
AustriaStudy on Zanubrutinib for Patients with Primary Cold Agglutinin Disease
BelgiumStudy on Burfiralimab for Patients with Moderate to Severe Rheumatoid Arthritis
AustriaStudy of VRDN-001 for Patients with Thyroid Eye Disease Who Did Not Respond to Previous Treatment
CzechiaStudy on Switching to Islatravir and MK-8507 for Adults with HIV-1 Who Are Virologically Suppressed on a Drug Combination
FranceStudy on Afamelanotide and NB-UVB Light for Vitiligo Treatment in Patients with Vitiligo
FranceStudy on Guselkumab for Treating Active Psoriatic Arthritis in Patients with Inadequate Response to One Prior Anti-TNF Agent
BulgariaStudy on Long-Term Safety of Donidalorsen for Patients with Hereditary Angioedema
BelgiumLong-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
AustriaStudy on Maribavir for Treating Cytomegalovirus in Children and Adolescents Post-Transplant
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
